Investing in Biotech

Andy shares his journey from studying biochemistry and economics to becoming a seasoned investor in the biotech sector. He highlights the evolution of genomic sequencing, noting how advancements have transformed the landscape, making it faster and more affordable to understand genetic diseases. This progress opens up exciting opportunities for developing targeted therapies, reflecting a significant shift in the investment potential within healthcare.

In this clip
From this podcast
Capital Allocators – Inside the Institutional Investment Industry
[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Related Questions
- What is the history of genetics in relation to the episode George Church, PhD: Rewriting Genomes to Eradicate Disease and Aging and the clip Human Genome Project?

Investing in Biotech

In this clip

From this podcast

Capital Allocators – Inside the Institutional Investment Industry

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Related Questions

What is the history of genetics in relation to the episode George Church, PhD: Rewriting Genomes to Eradicate Disease and Aging and the clip Human Genome Project?